Nocardia farcinica

A Microbial Biorealm page on the genus Nocardia farcinica

Classification

Higher order taxa

Superkingdom: Bacteria
Phylum: Actinobacteria
Class: Actinobacteria
Subclass: Actinobacteridae
Order: Actinomycetales
Suborder: Corynebacterineae
Family: Nocardiaceae
Genus: Nocardia
(1)

Species

Nocardia farcinica
(1)

Description and significance

Species of the Nocardia Genus are Gram positive bacteria. Their cell envelope consists of a peptidoglycan cell wall, inside of which lay the cell membrane; a lipid bilayer with imbedded proteins. They are saprophytic; their habitats vary based on their need to grow and live on dead and/or decaying organic material. Soils, plants, animal tissues, and human tissues make ideal environments for growth. (3)

Farcinica are rod shaped but can fragment into coccoids. They are filamentous, produce endospores, are non motile, are obligate aerobes, and experience optimal growth at body temperature. (3,4) Nocardia colonies vary from white, to tan, orange and red in color. An image of Nocardia farcinica is not available for publication on MicrobeWiki at the date of this entry, but the following are provided for comparison:

All four images above show Nocardia asteroides grown on the same media, at the same temperature. Variances in size, color, and shape of colonies are apparent.
Images provided by CDC/Dr. William Kaplan


Left tube: Actinomadura madurae, Middle tube: Nocardia asteroides, Right tube: Micromonspora.
Image provided by CDC/Dr. David Berd

Nocardia farcinica images that are not available for publication on this site show colonies that are golden, to light, medium, and dark orange. The colonies appear globular and shiny with surfaces ranging from smooth to reticulated. (5,6) [1] and [2]

The genus Nocardia was first discovered Edmund Nocard, a French veterinarian, in 1889 as the cause of bovine infections. Nocardia farcinica is significant to modern medicine as it is a pathogen which threatens both human health and the health of important assets such as herds of cattle, horses, and many other animals. It is particularly resistant to treatment, and a high mortality rate among those infected. (7)

Genome structure

The genome of Nocardia farcinica containes a circular chromosome that is 6,021,225 base pairs long comprising 5,811 genes (8), and has a GC content of about 71%. Farcinica also has two plasmids; pNF1 & pNF2. pNF1 is 184,027 base pairs long, comprising 160 genes (8), and has a GC content of about 67%, while pNF2 is 87,093 base pairs long, comprising 93 genes(8), and its GC content is about 68%. (3) The defining characteristics about the various Nocardia species, including farcinica have been determined mainly by genomic sequencing of the 16S rRNA. (9)

Below is BacMap Genome Mapping, courtesy of Stothard P, Van Domselaar G, Shrivastava S, Guo A, O'Neill B, Cruz J, Ellison M, Wishart DS (2005) BacMap: an interactive picture atlas of annotated bacterial genomes. Nucleic Acids Res 33:D317-D320.
Detailed genomic information is available through BacMap [3]
********
Image 1: farcinica Chromosome
Image 2: pNF1 (Plasmid 1)
Image 3: pNF2 (Plasmid 2)

Cell structure and metabolism

Basic cell structure of N. farcinica:
Rod shaped, Gram positive, Mycolic acid cell wall, lipid bilayer cell membrane with associated proteins. The cell has one circular chromosome, and two plasmids. My research shows no indication of flagella, nor pilli on the N. farcinica species.

Nocardia species "form filamentous, branched cells which fragment into pleomorphic, rod-shaped, or coccoid elements... .filamentous cells protrude into the air away from the surface (aerial hyphae)"(11). All Mycolic acids comprising the cell wall of this bacteria are unsaturated, as opposed to some other Nocardia species such as asteroides who have a large quantity of saturated Mycolic acids. (10)

Metabolism:
N. farcinica carries out a broad variety of metabolic pathways. It's carbohydrate metabolism includes glycolysis, TCA cycle, pentose phosphate, and a long list of sugar metabolic pathways. Energy metabolic pathways include oxidative phosphorylation, methane, nitrogen, and sulfur metabolisms. Interestingly, N. farcinica carries out two photosynthetic pathways; the carbon fixation and reductive carboxylate cycle. (12) The research done on the metabolic pathways for N. farcinica is extensive and they can be viewed in detail on the N. farcinica site of the online Kyoto Encyclopedia of Genes and Genomes (KEGG) [4]

Secondary Metabolism:
Ishikawa, et al describes the high quantity of oxegenases found in N. farcinica and proposes that their purposes may be for fatty acid metabolism and defenses against toxins. It was also found that N. farcinica produces "bioactive molecules" through both the "mevalonate and the 'non' mevalonate pathways". (3)

Ecology & Pathology

Nocardia are parasitic bacteria which grow and reproduce on organic material. Their man habitat is carbon rich sources such as soils, and plant and animal tissues. Upon infection of a plant or animal host, it metabolizes necrotizing tissues for energy and nutrients. Because Nocardia can form endospores, transmission of the bacteria "aerogenically"(2) from one host to another is relatively easy, and the bacteria can survive dormantly when food sources are not present.

As stated, Nocardia infections can be transmitted aerogenically to host respiratory systems or wound sites, they can be introduced by innoculation (puncture wounds with the bacteria contaminant), and through fluid contact (ex: case reported of keratitis due to contaminated contact lense).(12)

How does this organism cause disease? Human, animal, plant hosts? Virulence factors, as well as patient symptoms.

Application to Biotechnology

Does this organism produce any useful compounds or enzymes? What are they and how are they used?

Current Research

Enter summaries of the most recent research here--at least three required

References

1. Wheeler DL, Chappey C, Lash AE, Leipe DD, Madden TL, Schuler GD, Tatusova TA, Rapp BA (2000). Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2000 Jan 1;28(1):10-4 [5]

2. J. Blümel, E. Blümel, A. F. Yassin, H. Schmidt-Rotte, and K. P. Schaal1. Typing of Nocardia farcinica by Pulsed-Field Gel Electophoresis Reveals an Endemic Strain as Source of Hospital Infections. J Clin Microbiol. 1998 January; 36(1): 118–122. [6]

3. Jun Ishikawa, Atsushi Yamashita, Yuzuru Mikami, Yasutaka Hoshino, Haruyo Kurita, Kunimoto Hotta, Tadayoshi Shiba, and Masahira Hattori. The complete genomic sequence of Nocardia farcinica IFM 10152. 2004 Oct 10.1073/pnas.0406410101. [7]

4. NCBI Genome Project > Nocardia farcinica IFM 10152 [NCBI]

5. Dept. of Bioactive Molecules, Nat Inst of Infectious Disease. Nocardia farcinica Genome Project 13117. [8]

6. Digital Atlas – Atlas of Actinomycetes, pg 2-8. Nat Inst of Infectious Disease. [9]

7. Munoz J, Mirelis B, et al., Clinical and microbiological features of nocardiosis 1997-2003. [10]

8. Stothard P, Van Domselaar G, Shrivastava S, Guo A, O'Neill B, Cruz J, Ellison M, Wishart DS (2005) BacMap: an interactive picture atlas of annotated bacterial genomes. Nucleic Acids Res 33:D317-D320 [11]

9. Barbara A. Brown-Elliott, June M. Brown, Patricia S. Conville, and Richard J. Wallace, Jr. Clinical and Laboratory Features of the Nocardia spp. Based on Current Molecular Taxonomy. Clin Microbiol Rev. 2006 April; 19(2): 259–282. [12]

10. Nischiuchi Y, Baba T, Hotta HH, Yano I. Mycolic acid analysis in Nocardia species. The mycolic acid compositions of Nocardia asteroides, N. farcinica, and N. nova. J Microbiol Methods, 1999 Aug, 37(2):111-22. [13]

11. B L Beaman and L Beaman, Nocardia species: host-parasite relationships. Clin Microbiol Rev. 1994 April; 7(2): 213–264. [14]

12. Catharina A. Eggink, Pieter Wesseling, et al. Severe Keratitis Due to Nocardia Farcinica. J of Clinical Microbiology, Apr 1997, p 99-1001. [15]

Edited by Julie Crownover, student of Rachel Larsen and Kit Pogliano